T0	Participants 91 175	laparoscopic radical hysterectomy and pelvic lymphadenectomy for gynecologic cancer.
T1	Participants 358 377	gynecologic tumors.
T2	Participants 506 594	Gynecologic Oncology Unit of the Catholic University of the Sacred Heart in Rome, Italy.
T3	Participants 604 945	Fifty patients with early cervical cancer (FIGO stages IA2, IB1, IIA <2 cm) or locally advanced cervical cancer (FIGO stages IB2, IIA >2cm, IIB) who received neoadjuvant treatment (chemotherapy or radiochemotherapy) and demonstrated a complete or partial clinical response and early stage endometrioid endometrial cancer (FIGO stages IB, II)
T4	Participants 1177 1289	Fifty patients were available for analysis, with 25 women randomly assigned to TB (arm A) and 25 to SES (arm B).
T5	Participants 1982 2011	patients with uterine cancer.